Core Insights - Morgan Stanley reports that UBTECH (09880) stands out in the rapidly evolving Chinese humanoid robot industry, becoming a high-growth company [1] - The company has conducted six rounds of placements since its IPO, which may raise investor concerns and controversies, but maintains an "Overweight" rating [1] Company Analysis - Frequent fundraising may reflect the capital intensity and competitive landscape of the industry [1] - The company is expected to secure three major government-led orders in November, which will likely drive revenue guidance up to a high single-digit growth rate [1] - Inclusion in the MSCI China Index is anticipated to further enhance liquidity and market visibility, attracting continued investor interest [1]
小摩：维持优必选(09880)“增持”评级 预期11月取得三份政府主导的重大订单